.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
MASAI RCT: 12% reduction in interval cancer rate using Transpara
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
As imaging volume increases, breast radiology workflow must adapt
.png)
As imaging volume increases, breast radiology workflow must adapt
Radiology faces an inflection point. Can systemic solutions, including AI, prioritize both patient outcomes and radiologist well-being?
July 03, 2025
Breast imaging is awash in data – Artificial Intelligence can help
.png)
Breast imaging is awash in data – Artificial Intelligence can help
Breast imaging has unique stressors compared to other areas of radiology that can contribute to radiologist fatigue and error: what can be done?
June 30, 2025
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
.png)
Podcast: ScreenPoint Co-Founder Talks Future of Breast Cancer Screening
Nico Karssemeijer, Chief Science Officer and Co-Founder of ScreenPoint Medical, joins Impact AI podcast to discuss how his team is revolutionizing breast cancer screening through cutting-edge AI.
June 10, 2025